Abstract
There are few reports on the relationship between the biological activity and structure of secondary metabolites from Dictyota dichotoma. In this work, the geometric and electronic structures, infrared spectra, ultraviolet spectra, 13C and 1H NMR spectra of 16 xenicane-type diterpenoids extracted from Dictyota dichotoma were studied by the density functional theory ωB97XD/6-311+G(2d,p) method. The analysis of the reactivity indices was carried out via the conceptual density functional theory. Furthermore, a pharmacodynamic evaluation was performed using ADME/Tox. The geometric structure analysis found that all 16 diterpenoids had the same unsaturated, branched chains and could be divided into two categories according to the ring size, including nine-membered and eight-membered rings. A hydroxyl group on the lactone ring reduced the stability of the compound. In contrast, a hydroxyl group on the parent ring had little effect on the compound’s stability. The electrostatic potential results preliminarily predicted active sites for nucleophilic/electrophilic reactions. The fitting results of infrared and nuclear magnetic resonance(NMR) data showed that the theoretical values obtained by this method were consistent with the experimental values. The UV-visible absorption spectra showed that the solvent effects caused different redshifts of the absorption peaks. The absorption strength was enhanced. The sixteen diterpenoids displayed a strong absorption peak in the range of 180–200 nm, but the compound containing a carbonyl group presents a weaker absorption peak in the field of 200–240 nm. Compounds 9―11, 14, and 15 have better stability and reactivity with lower chemical potentials and higher electronegativity, electrophilic index, and hardness values. The local reactivity descriptors further identified nucleophilic/electrophilic reaction sites for the sixteen compounds. Finally, the pharmacodynamic evaluation results predicted that compounds 2, 4, 8, 11, and 14―16 have optimal drugability. The theoretical results of this work may provide a rich data information for the other experimental study on the cembrane diterpenoids in medicine.
Similar content being viewed by others
References
El-Katony T. M., Deyab M. A., El-Adl M. F., El-Nabway W. F. M., Mol. Biol. Plants, 2020, 26, 1155
El-Shaibany A., Al-Habori M., Al-Maqtari T., Al-Mahbashi H., Flora S. J. S., Biomed. Res. Int., 2020, 2020, 2425693
Dixit D., Reddy C. R. K., Trivedi M. H., Gadhavi D. K., Sep. Sci. Plus., 2020, 3, 1
Vasavi T., Lavanya L. Y., Vani M., Uma M. D. P., J. Pharm. Clin. Res., 2019, 12, 520
Minicante S. A., Carlin S., Stocco M., Sfriso A., Capelli G., Montarsi F., J. Am. Mosq. Control Assoc., 2017, 33, 352
Malyarenko O. S., Usoltseva R. V, Zvyagintseva T. N., Ermakova S. P., Carbohydr. Polym., 2019, 206, 539
Agatonovic-Kustrin S., Kustrin E., Angoveb M. J., Morton D. W., J. Chromatogr. A, 2018, 1550, 57
Siless G. E., García M., Pérez M., Blustein G., Palermo J. A., J. Appl. Phycol., 2018, 30, 629
Benattouche Z., Bachir R. G., Russ. J. Mar. Biol., 2017, 43, 491
Parr R., Yang W., Density-functional Theory of Atoms and Molecules, Oxford University Press, New York, 1989
Chermette H., J. Comput. Chem., 1999, 20, 129
Geerlings P., Proft F. D., Langenaeker W., Chem. Rev., 2003, 103, 1793
Domingo L. R., Perez P., Org. Biomol. Chem., 2011, 9, 7168
Sánchez-Márquez J., Zorrilla D., García V., Fernández M., Mol. Phys., 2018, 116, 1737
Xu Z., Zhao J., Zhao D., Yang Z., Chin. J. Chem., 2020, 38, 1696
Vargas-Sánchez R. D., Mendoza-Wilson A. M., Balandrán-Quintana R. R., Torrescano-Urrutia G. R., Sánchez-Escalante A., Comput. Theor. Chem., 2015, 1058, 21
Wang L., Yang F., Zhao X., Li Y., Food Chem., 2019, 275, 339
Norma F. H., Juan F., Daniel G. M., Molecules, 2019, 24, 3312
Juan F., Norma F. H., Daniel G. M., Mar. Drugs, 2018, 16, 302
Norma F. H., Juan F., Daniel G. M., Mar. Drugs, 2020, 18, 478
Norma F. H., Juan F., Daniel G. M., Molecules, 2020, 25, 4158
Bugrim A., Nikolskaya T., Nikolsky Y., Drug Discov. Today, 2004, 9, 127
Ekins S., Andreyev S., Ryabov A., Kirillov E., Rakhmatulin E. A., Sorokina S., Bugrim A., Nikolskaya T., Drug Metab. Dispos., 2006, 34, 495
Advanced Chemistry Development Inc., (ACD/Labs), ACD/Percepta Version 2015, Frankfurt Am Main, 2016
da Cunha M. G., Franco G. C., Franchin M., Beutler J. A., de Alencar S. M., Ikegaki M., Rosalen P. L., Toxicol. Lett., 2016, 263, 6
Ribeiro A. R., Schmidt T. C., Chemosphere, 2017, 169, 524
Salzner U., Aydin A., J. Chem. Theory Comput., 2011, 7, 2568
Holtomo O., Motapon O., Nsangou M., J. Phys. Chem. A, 2019, 123, 10437
Sciortino G., Maréchal J. D., Fábián I., Lihi N., Garribba E., J. Inorg. Biochem., 2020, 204, 110953
Sun Y., Tsai M., Zhou W., Lu W., Liu J., J. Phys. Chem. B, 2019, 123, 10410
Miertuš S., Tomasi, J. Chem. Phys., 1982, 65, 239
Miertuš S., Scrocco E., Tomasi, J. Chem. Phys., 1981, 55, 117
Fu R., Lu T., Chen F., Acta Phys-chim Sin., 2014, 30, 628
Kar R., Pal S., Int. J. Quantum Chem., 2010, 110, 1642
Morell C., Grand A., Toro-Labbé A., Chem. Phys. Lett., 2006, 425, 342
Martínez-Araya J. I., J. Mol. Model., 2012, 18, 4299
Martínez-Araya J. I., J. Mol. Model., 2012, 19, 2715
Martínez-Araya J. I., J. Math. Chem., 2015, 53, 451
Chamorro E., Pérez P., Domingo L. R., Chem. Phys. Lett., 2013, 582, 141
Frisch M. J., Trucks G. W., Schlegel H. B., Gaussian 16 Revision B.01, Gaussian Inc, Wallingford CT, 2016
Lu T., Chen F. W., J. Comput. Chem., 2012, 33, 580
Zhao M., Cheng S. M., Yuan W. P., Dong J. Y., Huang K. X., Sun Z. M., Chem. Pharm. Bull., 2015, 63, 1081
Sun H. H., McEnroe F. J., William F., J. Org. Chem., 1983, 48, 1903
Midland S. L., Wing R. M., Sims J. J., J. Org. Chem., 1983, 48, 1906
Viano Y., Bonhomme D., Camps M., Briand J. F., Ortalo-Magné A., Blache Y., Culioli G., J. Nat. Prod., 2009, 72, 1299
Nobuyasu E., Ryoichi I., Takeshi M., Chem. Lett., 1982, 11, 1749
Norte M., González A. G., Arroyo P., Tetrahedron, 1990, 46, 6125
Finer J., Clardy J., Fenical W., Minale L., Ricco R., Battaile J., Kirkup M., Moore R. E., J. Org. Chem., 1979, 44, 2044
Jacquemin D., Preat J., Perpete E. A., Chem. Phys. Lett., 2005, 410, 254
Li L., Feng J., Ren A., Sun C., Chin. J. Chem., 2011, 29, 2263
Simon P. B. O., Jonathan L. N., Catherine H. L., Molecules, 2012, 17, 2929
Nageswari G., George G., Ramalingam S., Govindarajan M., J. Appl. Polym. Sci., 2018, 1166, 422
Othmani A., Bouzidi N., Viano Y., Alliche Z., Seridi H., Blache Y., Culioli G., J. Appl. Phycol., 2013, 26, 1573
Guella G., Chiasera G., Ndiaye I., Pietra F., Helv. Chim. Acta, 1994, 77, 1203
Panayiota S., Antonis B., Dimitra I., Phytochemistry, 2004, 65, 2025
Lipinski C. A., J. Pharmacol. Toxicol. Methods, 2000, 44, 235
Selick H. E., Beresford A. P., Tarbit M.H., Drug Discov. Today, 2002, 7, 109
Guo Z. R., Chin. J. Pharm., 2010, 45, 539
Li Y., Zhu C. Y., J. Liaocheng Univ., 2019, 32, 1
Zhang W. D., Sun H., Song S. S., Dai G. L., Bai Y. T., Ju W. Z., New Chin. Med. Clin. Pharmacol., 2019, 30, 695
Decleves X., Jacob A., Yousif S., Curr. Drug Metab., 2011, 12, 732
Elmeliegy M., Vourvahis M., Guo C. C., Wang D. D., Clin. Pharmacokinet., 2020, 59, 699
Acknowledgements
This work was supported by the National Natural Science Foundation of China(No. 21177098), the Zhejiang Provincial Natural Science Foundation, China(No. LY16B070006), and the Zhejiang Traditional Chinese Medicine Science and Technology Project, China(No. 2020ZB141).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflicts of interest.
Supporting Information
40242_2021_1296_MOESM1_ESM.pdf
Theoretical Study on the Structures, Spectral Properties and Druggability of Diterpenoids in Xenicane Type from Dictyota Dichotoma
Rights and permissions
About this article
Cite this article
Huang, L., Sun, X., Chen, M. et al. Theoretical Study on the Structures, Spectral Properties, and Drugability of Xenicane-type Diterpenoids from Dictyota dichotoma. Chem. Res. Chin. Univ. 38, 622–631 (2022). https://doi.org/10.1007/s40242-021-1296-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-021-1296-y